5 Oct

Johnson & Johnson Stock in the Week Ended October 5

WRITTEN BY Sarah Collins

Johnson & Johnson’s trading activity this week

On October 5, Johnson & Johnson (JNJ) stock opened at $137.43, a decline of ~0.51% compared to its closing price of $139.35 on October 4. Johnson & Johnson stock was trading at its 52-week high of $148.32 on January 17. It’s currently trading ~53.0% higher than its 52-week low of $118.62 reported on May 29.

Johnson & Johnson Stock in the Week Ended October 5

Over the last week, JNJ stock has risen ~0.82%. JNJ stock has risen ~4.2% over the last month. Year-to-date, JNJ stock has reported a decline of ~0.26%. The one-year stock price return for JNJ stands at ~4.9%. On October 5, Johnson & Johnson stock’s 50-day moving average was $137.60, and its 200-day moving average was $129.10.

Peers Pfizer (PFE), Mylan (MYL), and Abbott Laboratories (ABT) have registered respective stock price returns of 1.9%, -2.8%, and -1.6% over the last week.

Major events that triggered J&J’s recent stock performance

On October 4, Johnson & Johnson’s subsidiary Janssen and Prime Therapeutics entered into a value-based contract for Janssen’s Stelara, which is used for the treatment of psoriasis.

On the same day, Arrowhead Pharmaceuticals entered into a $3.7 billion license agreement for the development and commercialization of a gene-silencing drug for the treatment of Hepatitis B. On October 4, JNJ stock registered a rise of ~0.23%.

On October 2, JNJ stock rose by ~0.57%. On the day, Johnson & Johnson completed the divestiture of its LifeScan division to Platinum Equity. J&J had accepted the acquisition offer by Platinum Equity for J&J’s LifeScan business in June, as reported in An Investor’s Guide: Johnson & Johnson Updates.

On September 26, J&J’s subsidiary Depuy Synthes expanded its spine portfolio with a nerve assessment platform for use during spine surgery.

Be sure to check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data, as well as dividend information. Take a look!

Latest articles

Tesla (TSLA) stock short sellers seem to be getting exasperated. Notably, Tesla stock has been the short sellers’ favorite.

In the week that ended on November 15, natural gas prices fell 3.5% and settled at 2.688 per MMBtu (million British thermal units).

The Dow Jones Index (DIA) and S&P 500 (SPY) are trading at record highs and on Friday the Dow Jones crossed the 28,000 level for the first time.

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

In the November 14 trading session, Aurora Cannabis (ACB) stock fell 12.7% from the previous session during after-hours trading.